- Home
- IVA vs TBRG Comparison
IVA vs TBRG Comparison
Compare IVA & TBRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVA
- TBRG
- Stock Information
- Founded
- IVA 2011
- TBRG 1979
- Country
- IVA France
- TBRG United States
- Employees
- IVA N/A
- TBRG N/A
- Industry
- IVA Biotechnology: Pharmaceutical Preparations
- TBRG
- Sector
- IVA Health Care
- TBRG
- Exchange
- IVA Nasdaq
- TBRG NYSE
- Market Cap
- IVA 359.6M
- TBRG 393.0M
- IPO Year
- IVA 2020
- TBRG N/A
- Fundamental
- Price
- IVA $3.09
- TBRG $23.48
- Analyst Decision
- IVA Strong Buy
- TBRG Buy
- Analyst Count
- IVA 4
- TBRG 3
- Target Price
- IVA $10.50
- TBRG $23.67
- AVG Volume (30 Days)
- IVA 29.4K
- TBRG 216.2K
- Earning Date
- IVA 03-26-2025
- TBRG 08-07-2025
- Dividend Yield
- IVA N/A
- TBRG N/A
- EPS Growth
- IVA N/A
- TBRG N/A
- EPS
- IVA N/A
- TBRG N/A
- Revenue
- IVA $14,591,573.00
- TBRG $345,737,000.00
- Revenue This Year
- IVA $15.38
- TBRG $5.15
- Revenue Next Year
- IVA $24.22
- TBRG $5.25
- P/E Ratio
- IVA N/A
- TBRG N/A
- Revenue Growth
- IVA N/A
- TBRG 3.56
- 52 Week Low
- IVA $1.53
- TBRG $9.75
- 52 Week High
- IVA $4.05
- TBRG $32.00
- Technical
- Relative Strength Index (RSI)
- IVA 41.87
- TBRG 48.04
- Support Level
- IVA $3.00
- TBRG $22.10
- Resistance Level
- IVA $3.40
- TBRG $23.99
- Average True Range (ATR)
- IVA 0.20
- TBRG 0.84
- MACD
- IVA -0.04
- TBRG 0.09
- Stochastic Oscillator
- IVA 12.28
- TBRG 50.82
About IVA Inventiva S.A. American Depository Shares
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
About TBRG TRUBRIDGE INC
TruBridge Inc is a provider of healthcare solutions and services for community hospitals, clinics, and other healthcare systems. It provides services such as Electronic health records & information systems, revenue cycle management, population health, and data management, etc. The segments of the company are Revenue Cycle Management (RCM), (ii) Electronic Health Records (EHR), and (iii) Patient Engagement The company derives maximum revenue from the RCM segment.